Hyperthermic intraperitoneal chemotherapy (HIPEC) for primary advanced-stage or recurrent ovarian cancer: A systematic review and meta-analysis of randomized control trials

Gabriela Branquinho Guerra, Camila Mariana de Paiva Reis, Júnior Samuel Alonso de Menezes, Ana Paula Valério-Alves, Rafaela de Melo Sprogis, Raphaela Anderson Colares, Rafael Morriello

Open source

DOI
10.1016/j.ejso.2025.110424
Published
2025-11
Container
European Journal of Surgical Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejso.2025.110424,
  title = {Hyperthermic intraperitoneal chemotherapy (HIPEC) for primary advanced-stage or recurrent ovarian cancer: A systematic review and meta-analysis of randomized control trials},
  author = {Gabriela Branquinho Guerra and Camila Mariana de Paiva Reis and Júnior Samuel Alonso de Menezes and Ana Paula Valério-Alves and Rafaela de Melo Sprogis and Raphaela Anderson Colares and Rafael Morriello},
  year = {2025},
  journal = {European Journal of Surgical Oncology},
  doi = {10.1016/j.ejso.2025.110424},
  url = {https://doi.org/10.1016/j.ejso.2025.110424}
}

RIS

TY  - JOUR
TI  - Hyperthermic intraperitoneal chemotherapy (HIPEC) for primary advanced-stage or recurrent ovarian cancer: A systematic review and meta-analysis of randomized control trials
AU  - Gabriela Branquinho Guerra
AU  - Camila Mariana de Paiva Reis
AU  - Júnior Samuel Alonso de Menezes
AU  - Ana Paula Valério-Alves
AU  - Rafaela de Melo Sprogis
AU  - Raphaela Anderson Colares
AU  - Rafael Morriello
PY  - 2025
JO  - European Journal of Surgical Oncology
DO  - 10.1016/j.ejso.2025.110424
UR  - https://doi.org/10.1016/j.ejso.2025.110424
ER  - 

APA

Guerra, G. B., Reis, C. M. D. P., Menezes, J. S. A. D., Valério-Alves, A. P., Sprogis, R. D. M., Colares, R. A., & Morriello, R. (2025). Hyperthermic intraperitoneal chemotherapy (HIPEC) for primary advanced-stage or recurrent ovarian cancer: A systematic review and meta-analysis of randomized control trials. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110424

Source records